Human prothrombin complex (Hualan Biological Engineering)

人凝血酶原复合物 (华兰生物工程股份有限公司)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman prothrombin complex (Hualan Biological Engineering)
Drug Alias NameTangshuning
ClassificationBiologics > Protein drugs > Non-recombinant coagulation factorBiologics > Blood components > Non-recombinant coagulation factor
Mechanisms of ActionCoagulation factor VII modulatorsCoagulation factor X modulatorsCoagulation factor IX modulators +[4] 
TargetsCoagulation factor VIIProthrombinCoagulation factor IX +[4] 
Therapy Area/IndicationsHemophilia BFactor X DeficiencyBlood Coagulation Disorders
Global Approved IndicationsFactor X DeficiencyBlood Coagulation Disorders
Approved Indications in ChinaFactor X DeficiencyBlood Coagulation Disorders
Original Approved Country/TerritoryMainland China
Original Approved Date1999/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHualan Ankang Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHualan Biological Engineering Inc
Inactive CompaniesHualan Biological Engineering Chongqing Co Ltd
Active IndicationsFactor X DeficiencyBlood Coagulation Disorders
Inactive IndicationsHemophilia B

Other Information

ATC CodeB02BD01
Related LinksN/A